Literature DB >> 15243526

Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.

Yu-Fu Chen1, Pei-Yu Yang, Dan-Ning Hu, Feng-Sheng Kuo, Cheng-Sheng Hung, Chih-Ming Hung.   

Abstract

BACKGROUND: Despite the availability of various medical treatments for vitiligo, a large percentage of patients fail to achieve satisfactory results. Surgical techniques offer a potential solution for patients with vitiligo who fail to respond to medical treatments.
OBJECTIVE: We evaluated the practicality in treating vitiligo by using cultured autologous pure melanocytes and investigated the different results among stable localized vitiligo, stable generalized vitiligo, and active generalized vitiligo.
METHODS: In all, 120 patients with vitiligo were treated with transplantation of autologous cultured pure melanocyte suspension after carbon-dioxide laser abrasion.
RESULTS: Patients with stable localized vitiligo experienced the highest percentage of excellent repigmentation with 84% achieving 90% to 100% coverage, followed by 54% of patients with stable generalized vitiligo, whereas only 14% of patients with active generalized vitiligo experienced good repigmentation. Age and sex of the patients, and size and location of the lesions, did not show significant influence on the results of transplantation.
CONCLUSION: Autologous cultured pure melanocyte suspension combined with carbon-dioxide laser abrasion is an effective treatment for patients with stable vitiligo who fail to respond to medical treatments, especially for those with stable localized vitiligo.

Entities:  

Mesh:

Year:  2004        PMID: 15243526     DOI: 10.1016/j.jaad.2003.12.013

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Serum-free cultivation of adult normal human choroidal melanocytes.

Authors:  Monika Valtink; Katrin Engelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-26       Impact factor: 3.117

2.  Evaluation of Repigmentation with Cultured Melanocyte Transplantation (CMT) Compared with Non-Cultured Epidermal Cell Transplantation in Vitiligo at 12th Week Reveals Better Repigmentation with CMT.

Authors:  Gunjan Verma; Suraj R Varkhande; Hemanta K Kar; Rajni Rani
Journal:  J Invest Dermatol       Date:  2015-05-07       Impact factor: 8.551

Review 3.  Vitiligo in adults and children: surgical interventions.

Authors:  Rubeta Matin
Journal:  BMJ Clin Evid       Date:  2015-03-20

Review 4.  Melanocyte stem cells as potential therapeutics in skin disorders.

Authors:  Ju Hee Lee; David E Fisher
Journal:  Expert Opin Biol Ther       Date:  2014-08-08       Impact factor: 4.388

5.  Current and emerging therapy for the management of vitiligo.

Authors:  Alicia Cecile Borderé; Jo Lambert; Nanny van Geel
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-03-12

Review 6.  Grafting in vitiligo: how to get better results and how to avoid complications.

Authors:  Imran Majid
Journal:  J Cutan Aesthet Surg       Date:  2013-04

7.  High correlation between skin color based on CIELAB color space, epidermal melanocyte ratio, and melanocyte melanin content.

Authors:  Wen-Shyan Huang; Yi-Wen Wang; Kun-Che Hung; Pai-Shan Hsieh; Keng-Yen Fu; Lien-Guo Dai; Nien-Hsien Liou; Kuo-Hsing Ma; Jiang-Chuan Liu; Niann-Tzyy Dai
Journal:  PeerJ       Date:  2018-05-24       Impact factor: 2.984

Review 8.  Cultured Epidermal Melanocyte Transplantation in Vitiligo: A Review Article.

Authors:  Shaghayegh Zokaei; Dariush D Farhud; Mohammad Keykhaei; Marjan Zarif Yeganeh; Hoda Rahimi; Hamideh Moravvej
Journal:  Iran J Public Health       Date:  2019-03       Impact factor: 1.429

9.  Differentiation of adipose-derived stem cells to functional CD105neg CD73low melanocyte precursors guided by defined culture condition.

Authors:  Gabriela Zavala; Carolina Sandoval; Daniel Meza; Rafael Contreras; Walter Gubelin; Maroun Khoury
Journal:  Stem Cell Res Ther       Date:  2019-08-09       Impact factor: 6.832

10.  Cellular grafts in management of leucoderma.

Authors:  Venkataram Mysore; T Salim
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.